6/3/2021 8:13:53 AM
Aeterna Zentaris Reports Final Settlement Of Previously Disclosed Class-Action Lawsuit
5/17/2021 8:23:17 AM
Aeterna Reports Start Of Preclinical Development Of Macimorelin At The University Of Queensland
3/25/2021 8:10:12 AM
Aeterna Zentaris Q4 Total Revenue $2.4 Mln Vs $0.02 Mln Last Year
3/11/2021 8:09:06 AM
Aeterna Zentaris Initiate Preclinical Program For Potential Treatment Of Primary Hypoparathyroidism
3/29/2012 10:58:40 AM
RBC Capital Markets Is Increasing AEterna Zentaris Inc (AEZS) Q4 12 Rev. Estimate To 10.8 M From 10.2 M
3/29/2012 10:57:57 AM
RBC Capital Markets Is Increasing AEterna Zentaris Inc (AEZS) Q3 12 Rev. Estimate To 13.7 M From 13.5 M
3/29/2012 10:57:20 AM
RBC Capital Markets Is Raising AEterna Zentaris Inc (AEZS) Q2 12 Rev. Estimate To 7.5 M From 7.3 M
3/29/2012 10:56:37 AM
RBC Capital Markets Is Cutting AEterna Zentaris Inc (AEZS) Q1 12 Rev. Estimate To 7.8 M From 11.1 M
3/29/2012 10:56:01 AM
RBC Capital Markets Is Raising AEterna Zentaris Inc (AEZS) FY 13 Rev. Estimate To 44.4 M From 41.3 M
3/29/2012 10:55:14 AM
RBC Capital Markets Is Cutting AEterna Zentaris Inc (AEZS) FY 12 Rev. Estimate To 39.7 M From 42.0 M
3/29/2012 10:53:56 AM
RBC Capital Markets Is Cutting AEterna Zentaris Inc (AEZS) Q4 12 Estimate To -0.07 From -0.06
3/29/2012 10:53:25 AM
RBC Capital Markets Is Lowering AEterna Zentaris Inc (AEZS) Q3 12 Estimate To -0.04 From -0.03
3/29/2012 10:52:56 AM
RBC Capital Markets Is Increasing AEterna Zentaris Inc (AEZS) Q2 12 Estimate To -0.08 From -0.09
3/29/2012 10:52:32 AM
RBC Capital Markets Is Lowering AEterna Zentaris Inc (AEZS) Q1 12 Estimate To -0.09 From -0.06
3/29/2012 10:51:42 AM
RBC Capital Markets Is Cutting AEterna Zentaris Inc (AEZS) FY 13 Estimate To -0.21 From -0.20